IFM Investors’s United Therapeutics UTHR Stock Holding History

IFM Investors’s Portfolio UTHR Stock Details UTHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.24M	Buy	9,675 +797	+9%	+$449K	0.03%	402
2026 Q1	$5.26M	Buy	+8,878	New	+$4.42M	0.04%	359
2025 Q4	–	Sell	-8,647	Closed	-$3.74M	–	663
2025 Q3	$3.74M	Buy	8,647 +128	+2%	+$43K	0.03%	427
2025 Q2	$2.45M	Buy	8,519 +529	+7%	+$158K	0.02%	480
2025 Q1	$2.46M	Sell	7,990 -208	-3%	-$71.3K	0.03%	472
2024 Q4	$2.89M	Sell	8,198 -484	-6%	-$178K	0.03%	460
2024 Q3	$3.11M	Sell	8,682 -659	-7%	-$223K	0.03%	458
2024 Q2	$2.98M	Sell	9,341 -401	-4%	-$106K	0.03%	455
2024 Q1	$2.24M	Buy	+9,742	New	+$2.2M	0.02%	506
2023 Q4	–	Sell	-7,884	Closed	-$1.78M	–	632
2023 Q3	$1.78M	Hold	7,884	–	–	0.02%	526
2023 Q2	$1.74M	Buy	7,884 +151	+2%	+$33.4K	0.02%	527
2023 Q1	$1.73M	Buy	+7,733	New	+$1.91M	0.03%	516
2019 Q2	–	Sell	-2,644	Closed	-$310K	–	616
2019 Q1	$310K	Hold	2,644	–	–	0.02%	569
2018 Q4	$288K	Buy	2,644 +288	+12%	+$33.4K	0.02%	553
2018 Q3	$301K	Buy	+2,356	New	+$291K	0.02%	568

Other funds holding UTHR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Norges Bank Oslo, Norway $1T AUM

IFM Investors's UTHR Position: Q2 2026 in Review

IFM Investors increased its United Therapeutics (UTHR) stake by 9% in Q2 2026, buying an estimated $449K and bringing the position to 9,675 shares worth $5.24M. The position accounts for 0.03% of the portfolio, ranked #402.

IFM Investors first reported a position in UTHR in Q3 2018 and has held it in 15 quarters since. The position peaked at $5.26M in Q1 2026. 880 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

IFM Investors held 9,675 shares of United Therapeutics worth $5.24M as of Q2 2026.
IFM Investors bought 797 United Therapeutics shares in Q2 2026, an estimated $449K.
United Therapeutics made up 0.03% of IFM Investors's portfolio in Q2 2026, its #402 holding.
IFM Investors first reported a position in United Therapeutics in Q3 2018 and has held it in 15 quarters since.
IFM Investors's United Therapeutics position peaked at $5.26M in Q1 2026.
880 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on IFM Investors's 13F filing for Q2 2026, filed 21 Jul 2026.